曼月乐治疗子宫内膜异位症的效用分析

Efficacy analysis of menyuele in the treatment of endometriosis

目的:探讨曼月乐对子宫内膜异位症的治疗效果。方法:选取98例我院在2015年12月—2018年12月收治的子宫内膜异位症患者进行研究,按照入院顺序分成对照组和观察组,各49例。对照组用妈富隆治疗,观察组用曼月乐治疗,比较两组治疗情况。结果:观察组疾病治疗总有效率高于对照组,不良反应发生率低于对照组(95.92%VS79.59%,6.12%VS22.45%)(P<0.05);两组治疗前疼痛程度、子宫内膜厚度、糖类抗原125水平对比差异无统计学意义(P>0.05),观察组治疗后痛程度、子宫内膜厚度、糖类抗原125水平低于对照组[(4.98±1.09)分VS(5.72±1.32)分,(0.58±0.15)cmVS(0.68±0.16)cm,(59.34±1.81)U/mLVS(60.28±1.76)U/mL](P<0.05)。结论:在子宫内膜异位症的治疗中使用曼月乐,可提高治疗效果,缓解疼痛感,降低不良反应发生风险,推广应用价值高。

Objective:To explore the therapeutic effect of Manyuele on endometriosis.Methods:A total of 98 patients with endometriosis in our hospital from December 2015 to December 2018 were divided into control group and observation group The treatment of the two groups was compared.Results:The total effective rate of the observation group was higher than that of the control group,and the incidence of adverse reactions was lower than that of the control group(95.92%vs 79.59%,6.12%vs 22.45%,P<0.05),There was no difference in pain,endometrial thickness,and carbohydrate antigen level between the two groups before treatment(P>0.05)After treatment,the pain degree,endometrial thickness and the level of carbohydrate Antigen 125 in the observation group were(4.98±1.09)minutes vs(5.72±1.32)minutes,(0.58±0.15)cm vs(0.68±0.16)cm,(59.34±1.81)U/mL vs(60.28±1.76)U/mL,(P<0.05).Conclusion:The use of endometriosis in the treatment can improve the therapeutic effect,relieve pain,reduce the risk of adverse reactions,and has high application value.